CN1225466C - Ⅰ型钠－氢交换剂(nhe－1)抑制剂 - Google Patents
Ⅰ型钠－氢交换剂(nhe－1)抑制剂 Download PDFInfo
- Publication number
- CN1225466C CN1225466C CNB018087256A CN01808725A CN1225466C CN 1225466 C CN1225466 C CN 1225466C CN B018087256 A CNB018087256 A CN B018087256A CN 01808725 A CN01808725 A CN 01808725A CN 1225466 C CN1225466 C CN 1225466C
- Authority
- CN
- China
- Prior art keywords
- compound
- application
- tissue
- prodrug
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Treatment Of Water By Ion Exchange (AREA)
- Preventing Corrosion Or Incrustation Of Metals (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20043200P | 2000-04-28 | 2000-04-28 | |
| US60/200,432 | 2000-04-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1426404A CN1426404A (zh) | 2003-06-25 |
| CN1225466C true CN1225466C (zh) | 2005-11-02 |
Family
ID=22741697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB018087256A Expired - Fee Related CN1225466C (zh) | 2000-04-28 | 2001-02-28 | Ⅰ型钠－氢交换剂(nhe－1)抑制剂 |
Country Status (40)
| Country | Link |
|---|---|
| EP (1) | EP1276737A1 (cs) |
| JP (1) | JP2003531900A (cs) |
| KR (1) | KR20020093079A (cs) |
| CN (1) | CN1225466C (cs) |
| AP (1) | AP2002002651A0 (cs) |
| AR (1) | AR028375A1 (cs) |
| AU (1) | AU2001235896A1 (cs) |
| BG (1) | BG107139A (cs) |
| BR (1) | BR0110268A (cs) |
| CA (1) | CA2407535A1 (cs) |
| CO (1) | CO5221125A1 (cs) |
| CR (1) | CR6797A (cs) |
| CZ (1) | CZ20023408A3 (cs) |
| DZ (1) | DZ3310A1 (cs) |
| EA (1) | EA004882B1 (cs) |
| EE (1) | EE200200615A (cs) |
| GT (1) | GT200100064A (cs) |
| HN (1) | HN2001000042A (cs) |
| HR (1) | HRP20020851A2 (cs) |
| HU (1) | HUP0300651A2 (cs) |
| IL (1) | IL152075A0 (cs) |
| IS (2) | IS6567A (cs) |
| MA (1) | MA26897A1 (cs) |
| MX (1) | MXPA02010600A (cs) |
| MY (1) | MY133842A (cs) |
| NO (1) | NO20025132L (cs) |
| NZ (1) | NZ521348A (cs) |
| OA (1) | OA12256A (cs) |
| PA (1) | PA8513301A1 (cs) |
| PE (1) | PE20011270A1 (cs) |
| PL (1) | PL357765A1 (cs) |
| SK (1) | SK14872002A3 (cs) |
| SV (1) | SV2002000418A (cs) |
| TN (1) | TNSN01065A1 (cs) |
| TR (1) | TR200202439T2 (cs) |
| UA (1) | UA73348C2 (cs) |
| UY (1) | UY26680A1 (cs) |
| WO (1) | WO2001083470A1 (cs) |
| YU (1) | YU79602A (cs) |
| ZA (1) | ZA200208605B (cs) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1479737A (zh) * | 2001-01-31 | 2004-03-03 | �Ʒ� | 钠-质子交换蛋白1型抑制剂的乙醇盐 |
| CA2469305A1 (en) * | 2001-12-19 | 2003-06-26 | Frank Robert Busch | Methods for preparing sodium-hydrogen exchanger type-1 inhibitors |
| WO2003092694A1 (en) * | 2002-05-02 | 2003-11-13 | Pfizer Products Inc. | Treatment of diabetes and diabetic complications with nhe-1 inhibitors |
| FR2840302B1 (fr) * | 2002-06-03 | 2004-07-16 | Aventis Pharma Sa | Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant |
| ES2220185B1 (es) * | 2002-07-16 | 2006-04-01 | Consejo Sup. De Investig. Cientificas | Nuevo peptido inhibidor del intercambiador na+/h+ (pinhe), y sus aplicaciones. |
| WO2004073628A2 (en) * | 2003-02-14 | 2004-09-02 | Smithkline Beecham Corporation | Novel compounds |
| RU2518741C1 (ru) * | 2013-03-22 | 2014-06-10 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" | СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ГАЛОГЕНИДЫ 1-ДИАЛКИЛАМИНОЭТИЛ-3-[ЗАМЕЩЕННЫЙ(ДИЗАМЕЩЕННЫЙ) ФЕНАЦИЛ]-2-АМИНОБЕНЗИМИДАЗОЛИЯ |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK12342000A3 (sk) * | 1998-02-27 | 2001-03-12 | Pfizer Products Inc. | Deriváty n-[(substituovaný päťčlenný di-alebo triáza-di- -nenasýtený kruh)karbonyl] guanidínu pre liečenie ischémie |
-
2001
- 2001-02-28 HU HU0300651A patent/HUP0300651A2/hu unknown
- 2001-02-28 CA CA002407535A patent/CA2407535A1/en not_active Abandoned
- 2001-02-28 AP APAP/P/2002/002651A patent/AP2002002651A0/en unknown
- 2001-02-28 CN CNB018087256A patent/CN1225466C/zh not_active Expired - Fee Related
- 2001-02-28 UA UA2002108497A patent/UA73348C2/uk unknown
- 2001-02-28 OA OA1200200331A patent/OA12256A/en unknown
- 2001-02-28 DZ DZ013310A patent/DZ3310A1/fr active
- 2001-02-28 PL PL01357765A patent/PL357765A1/xx not_active Application Discontinuation
- 2001-02-28 YU YUP-796/02A patent/YU79602A/sh unknown
- 2001-02-28 EA EA200201023A patent/EA004882B1/ru not_active IP Right Cessation
- 2001-02-28 MX MXPA02010600A patent/MXPA02010600A/es active IP Right Grant
- 2001-02-28 CZ CZ20023408A patent/CZ20023408A3/cs unknown
- 2001-02-28 BR BR0110268-0A patent/BR0110268A/pt not_active IP Right Cessation
- 2001-02-28 WO PCT/IB2001/000277 patent/WO2001083470A1/en not_active Application Discontinuation
- 2001-02-28 SK SK1487-2002A patent/SK14872002A3/sk unknown
- 2001-02-28 JP JP2001580898A patent/JP2003531900A/ja active Pending
- 2001-02-28 EE EEP200200615A patent/EE200200615A/xx unknown
- 2001-02-28 KR KR1020027014355A patent/KR20020093079A/ko active IP Right Grant
- 2001-02-28 NZ NZ521348A patent/NZ521348A/en unknown
- 2001-02-28 IL IL15207501A patent/IL152075A0/xx unknown
- 2001-02-28 AU AU2001235896A patent/AU2001235896A1/en not_active Abandoned
- 2001-02-28 EP EP01908037A patent/EP1276737A1/en not_active Withdrawn
- 2001-02-28 TR TR2002/02439T patent/TR200202439T2/xx unknown
- 2001-03-06 HN HN2001000042A patent/HN2001000042A/es unknown
- 2001-03-12 PA PA20018513301A patent/PA8513301A1/es unknown
- 2001-04-20 GT GT200100064A patent/GT200100064A/es unknown
- 2001-04-24 UY UY26680A patent/UY26680A1/es not_active Application Discontinuation
- 2001-04-26 PE PE2001000376A patent/PE20011270A1/es not_active Application Discontinuation
- 2001-04-26 MY MYPI20011977A patent/MY133842A/en unknown
- 2001-04-26 AR ARP010101970A patent/AR028375A1/es unknown
- 2001-04-27 CO CO01032977A patent/CO5221125A1/es not_active Application Discontinuation
- 2001-04-27 TN TNTNSN01065A patent/TNSN01065A1/fr unknown
- 2001-04-27 SV SV2001000418A patent/SV2002000418A/es not_active Application Discontinuation
-
2002
- 2002-09-23 BG BG107139A patent/BG107139A/bg unknown
- 2002-09-24 IS IS6567A patent/IS6567A/is unknown
- 2002-10-18 CR CR6797A patent/CR6797A/es not_active Application Discontinuation
- 2002-10-18 MA MA26875A patent/MA26897A1/fr unknown
- 2002-10-21 IS IS6588A patent/IS6588A/is unknown
- 2002-10-24 ZA ZA200208605A patent/ZA200208605B/en unknown
- 2002-10-25 HR HR20020851A patent/HRP20020851A2/hr not_active Application Discontinuation
- 2002-10-25 NO NO20025132A patent/NO20025132L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1245974C (zh) | 卡维地洛 | |
| CN1234705C (zh) | 新的羟基吲哚、其作为磷酸二酯酶4抑制剂的应用及其制备方法 | |
| JP5589090B2 (ja) | 癌ならびに免疫疾患および自己免疫疾患の治療用のアポトーシス誘発剤 | |
| CN107531682B (zh) | B-raf激酶抑制剂的马来酸盐、其结晶形式、制备方法和用途 | |
| CN102834388B (zh) | Cgrp受体拮抗剂 | |
| KR20150028971A (ko) | 항바이러스성 화합물의 고체 형태 | |
| CN1612866A (zh) | 无定形和结晶形的氯沙坦钾及其制备方法 | |
| CN1976925A (zh) | 吡咯基嘧啶erk蛋白激酶抑制剂的前体药物 | |
| US8039485B2 (en) | Malate salts, and polymorphs of (3S,5S)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid | |
| CN113735828B (zh) | 一种靶向降解egfr的化合物及其制备方法和应用 | |
| CN1261887A (zh) | 氮杂环丁基丙基哌啶衍生物、中间体以及作为速激肽拮抗剂的用途 | |
| JP2013537240A (ja) | 糖尿病および脂質異常症の処置のための方法および組成物 | |
| CN1225466C (zh) | Ⅰ型钠－氢交换剂(nhe－1)抑制剂 | |
| US20130197034A1 (en) | Salts Of Methyl 2-((R)-(3-Chlorophenyl)((R)-1-((S)-2-(Methylamino)-3-((R)-Tetrahydro-2H-Pyran-3-Yl)Propylcarbamoyl)Piperidin-3-Yl)Methoxy)Ethylcarbamate | |
| CN109897036B (zh) | 三唑并吡啶类化合物及其制备方法和用途 | |
| CN1039644C (zh) | 神经保护性3,4-二氢-2(1h)-喹诺酮类化合物及应用 | |
| CN1232452A (zh) | Nmda(n－甲基－d－天冬氨酸)拮抗剂 | |
| CN1699342A (zh) | 新的羟基吲哚、其作为磷酸二酯酶4抑制剂的应用及其制备方法 | |
| CN1726208A (zh) | E－2－甲氧基－n－( 3－{4－[3－甲基－4－( 6－甲基－吡啶－3－基氧基)－苯基氨基]－喹唑啉－6－基}－烯丙基)－乙酰胺的配合物、其制备方法和用途 | |
| CN1265652A (zh) | 用作速激肽受体拮抗剂的2－酰基氨基丙胺化合物 | |
| CN1303379A (zh) | 作为氧化氮合酶抑制剂的含稠环取代基的2－氨基吡啶 | |
| US20060293375A1 (en) | Crystal of benzimidazole derivative and process for producing the same | |
| US6852733B2 (en) | Sodium-hydrogen exchanger type 1 inhibitor | |
| TW315367B (cs) | ||
| CA3213086A1 (en) | Process for preparation of cabozantinib |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1056723 Country of ref document: HK |